Erratum: Inhibition of arenaviruses by combinations of orally available approved drugs (Antimicrobial Agents and Chemotherapy (2021) 65:4 (e01146-20) DOI: 10.1128/AAC.01146-20)

  • Shawn Herring
  • , Jessica M. Oda
  • , Jessica Wagoner
  • , Delaney Kirchmeier
  • , Aidan O’Connor
  • , Elizabeth A. Nelson
  • , Qinfeng Huang
  • , Yuying Liang
  • , Lisa Evans DeWald
  • , Lisa M. Johansen
  • , Pamela J. Glass
  • , Gene G. Olinger
  • , Aleksandr Ianevski
  • , Tero Aittokallio
  • , Mary F. Paine
  • , Susan L. Fink
  • , Judith M. White
  • , Stephen J. Polyak

Research output: Contribution to journalComment/debatepeer-review

Abstract

Volume 65, no. 4, e01146-20, 2021, https://doi.org/10.1128/AAC.01146-20. Table 1: several rows in panels C and D were mislabeled with the wrong drug names, and two values in the “Obs” column of panel C were incorrect. The correct table is shown below. (Table Presented).

Original languageEnglish (US)
Article numbere00653
JournalAntimicrobial agents and chemotherapy
Volume65
Issue number6
DOIs
StatePublished - Jun 2021
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Erratum: Inhibition of arenaviruses by combinations of orally available approved drugs (Antimicrobial Agents and Chemotherapy (2021) 65:4 (e01146-20) DOI: 10.1128/AAC.01146-20)'. Together they form a unique fingerprint.

Cite this